Who is sponsoring NCT03930524?

NCT03930524 is sponsored by University of Minnesota.

What drugs are being tested in NCT03930524?

Interventions in NCT03930524: Personalized Normative Feedback (PNF), Self-Monitoring (SM), Web-BASICS, Health Promotion Consultation, M-Bridge Online Health Coach.

What condition does NCT03930524 study?

NCT03930524 studies College Student Drinking.

Is NCT03930524 still recruiting?

NCT03930524 is currently completed. Last updated 12 April 2023.

Are results published for NCT03930524?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-04-12 · How we verify

NCT03930524

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adaptive Preventive Intervention for College Alcohol Use

Completed NA Results posted Last updated 12 April 2023

What this trial tests

NA trial testing Personalized Normative Feedback (PNF) in College Student Drinking in 891 participants. Completed in 1 August 2022.

Timeline

31 July 2019

Primary endpoint
1 August 2022

1 August 2022

Quick facts

Lead sponsor	University of Minnesota
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	none
Primary purpose	prevention
Enrollment	891
Start date	31 July 2019
Primary completion	1 August 2022
Estimated completion	1 August 2022
Sites	1 location across United States

Drugs / interventions tested

Personalized Normative Feedback (PNF)
Self-Monitoring (SM)
Web-BASICS
Health Promotion Consultation
M-Bridge Online Health Coach

Conditions studied

College Student Drinking — all drugs for College Student Drinking →

Sponsor

University of Minnesota

Who can join

Adults 18 to 21, any sex, with College Student Drinking. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Binge Drinking Primary · 3 months

Respondents are asked about the frequency of consuming 4/5+ drinks within a two-hour period in the past 30 days. Questions are based on NIAAA recommended alcohol questions (https://www.niaaa.nih.gov/research/guidelines-and-resources/recommended-alcohol-questions) and Monitoring the Future survey items (http://www.monitoringthefuture.org/).

Group	Value	95% CI
Adaptive Preventive Intervention (API)	1.034	± 1.706
Assessment Only	1.129	± 1.843

Sponsor's own description

This research project is designed to promote health among first-year college students by implementing an adaptive sequence of preventive intervention strategies to motivate heavy-drinking college students to access existing resources in order to reduce high-risk alcohol use and negative consequences. If found efficacious, the adaptive preventive intervention (API) has the potential to reduce both the acute negative health consequences (e.g., injury, alcohol poisoning) and long-term health consequences (e.g., alcohol use disorders) of young adult alcohol use, while seeking to leverage technology in order to use campus resources in the most efficient way possible.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Main outcomes of M-bridge: A sequential multiple assignment randomized trial (SMART) for developing an adaptive preventive intervention for college drinking.
Patrick ME, Lyden GR, Morrell N, Mehus CJ, et al · · 2021 · cited 25× · PMID 34383533 · DOI 10.1037/ccp0000663

Verify or expand the search:

Other University of Minnesota trials

Trials by the same sponsor.

NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03930524 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
Last refreshed: 12 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03930524.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing